Filing Details

Accession Number:
0001209191-11-056360
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-11-16 14:50:37
Reporting Period:
2011-11-14
Filing Date:
2011-11-16
Accepted Time:
2011-11-16 14:50:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1107332 Dendreon Corp DNDN Pharmaceutical Preparations (2834) 223203193
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1420482 W Mark Frohlich 1301 2Nd Ave
Suite 3200
Seattle WA 98101
See General Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-11-14 1,248 $4.90 189,042 No 4 M Direct
Common Stock Disposition 2011-11-14 7,500 $7.20 181,542 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Incentive Stock Option (right to buy) Disposition 2011-11-14 1,248 $7.27 1,248 $4.90
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
312 2017-12-05 No 4 M Direct
Footnotes
  1. These options vest as follows: 25% of the total number of shares on the first anniversary date and, thereafter, at a rate of 1/36 of the total number of shares in equal monthly installments.